X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Fresenius Kabi Onco. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs FRESENIUS KABI ONCO. - Comparison Results

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE FRESENIUS KABI ONCO. TTK HEALTHCARE/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 51.5 22.1 232.8% View Chart
P/BV x 9.5 3.1 304.8% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 TTK HEALTHCARE   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
FRESENIUS KABI ONCO.
Mar-13
TTK HEALTHCARE/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs663176 376.9%   
Low Rs39979 508.3%   
Sales per share (Unadj.) Rs535.637.7 1,421.3%  
Earnings per share (Unadj.) Rs15.95.1 313.1%  
Cash flow per share (Unadj.) Rs20.06.7 297.9%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs137.642.5 323.5%  
Shares outstanding (eoy) m7.77158.23 4.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.4 29.4%   
Avg P/E ratio x33.325.0 133.3%  
P/CF ratio (eoy) x26.518.9 140.1%  
Price / Book Value ratio x3.93.0 129.1%  
Dividend payout %25.10-   
Avg Mkt Cap Rs m4,12720,135 20.5%   
No. of employees `0001.71.2 148.3%   
Total wages/salary Rs m607703 86.3%   
Avg. sales/employee Rs Th2,436.75,176.2 47.1%   
Avg. wages/employee Rs Th355.2610.4 58.2%   
Avg. net profit/employee Rs Th72.5699.6 10.4%   
INCOME DATA
Net Sales Rs m4,1625,963 69.8%  
Other income Rs m6118 340.0%   
Total revenues Rs m4,2235,981 70.6%   
Gross profit Rs m1971,430 13.8%  
Depreciation Rs m32258 12.3%   
Interest Rs m30-26 -115.0%   
Profit before tax Rs m1971,216 16.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m73342 21.3%   
Profit after tax Rs m124806 15.4%  
Gross profit margin %4.724.0 19.7%  
Effective tax rate %37.028.1 131.5%   
Net profit margin %3.013.5 22.0%  
BALANCE SHEET DATA
Current assets Rs m1,6295,102 31.9%   
Current liabilities Rs m1,0582,385 44.3%   
Net working cap to sales %13.745.6 30.1%  
Current ratio x1.52.1 72.0%  
Inventory Days Days30150 19.8%  
Debtors Days Days34113 29.6%  
Net fixed assets Rs m5565,148 10.8%   
Share capital Rs m78158 49.1%   
"Free" reserves Rs m8786,556 13.4%   
Net worth Rs m1,0696,732 15.9%   
Long term debt Rs m159952 16.7%   
Total assets Rs m2,39910,388 23.1%  
Interest coverage x7.6-45.8 -16.6%   
Debt to equity ratio x0.10.1 104.9%  
Sales to assets ratio x1.70.6 302.2%   
Return on assets %6.47.5 85.4%  
Return on equity %11.612.0 96.8%  
Return on capital %18.514.6 126.4%  
Exports to sales %0.874.5 1.1%   
Imports to sales %1.424.8 5.7%   
Exports (fob) Rs m334,441 0.7%   
Imports (cif) Rs m581,477 3.9%   
Fx inflow Rs m335,298 0.6%   
Fx outflow Rs m631,772 3.6%   
Net fx Rs m-303,525 -0.9%   
CASH FLOW
From Operations Rs m1271,274 9.9%  
From Investments Rs m-146-1,204 12.1%  
From Financial Activity Rs m22-196 -11.2%  
Net Cashflow Rs m3-126 -2.0%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 3.7 0.3 1,233.3%  
FIIs % 5.2 9.6 54.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 9.1 283.5%  
Shareholders   12,723 42,599 29.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   CADILA HEALTHCARE  J.B.CHEMICALS  ORCHID PHARMA LTD  BIOCON LTD  FULFORD INDIA  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Strong US Markets; SBI, Tata Steel & Other Top Cues to Sway the Markets Today(Pre-Open)

After opening the day in green, share markets in India witnessed negative trading activity throughout the day and ended the day on a weak note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 16, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS